Cetuximab and Recombinant Interleukin-12 in Treating Patients With Squamous Cell Carcinoma of the Head and Neck That is Recurrent, Metastatic, or Cannot Be Removed by Surgery
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Ensem Therapeutics
AstraZeneca
Genmab
Mayo Clinic
H. Lee Moffitt Cancer Center and Research Institute
STORM Therapeutics LTD
Tubulis GmbH
Alentis Therapeutics AG
Eli Lilly and Company
Neonc Technologies, Inc.
Ipsen
Sumitomo Pharma America, Inc.
Terremoto Biosciences Inc.
Bristol-Myers Squibb
University of Washington
NYU Langone Health
Merus B.V.